Dr. Mohammed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 2012 - 2015
- University of Wisconsin Hospitals and ClinicsChief Residency, Internal Medicine, 2011 - 2012
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2008 - 2011
- Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2008
- Rush University Medical CenterMS, Cell Biology, 2002 - 2004
- Rush University Medical CenterM.S., Anatomy & Cell Biology, 2002 - 2004
- University of Illinois at Urbana-ChampaignB.S., Liberal Arts & Sciences, 1999 - 2002
Certifications & Licensure
- IL State License 2014 - 2026
- WI State License 2009 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Certificate of Recognition Representative Tammy Baldwin, US House of Representatives, 2012
- Summer Research Fellowship American Osteopathic Association, 2005
Publications & Presentations
PubMed
- 38 citationsA phase i study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancerWilliam R. Schelman, Tabraiz A. Mohammed, Anne M. Traynor, Jill M. Kolesar, Rebecca Marnocha
Investigational New Drugs. 2014-04-01 - 69 citationsA Pilot Phase II Study of Valproic Acid for Treatment of Low-Grade Neuroendocrine CarcinomaTabraiz A. Mohammed, Kyle D. Holen, Renata Jaskula-Sztul, Daniel Mulkerin, Sam J. Lubner
The Oncologist. 2011-06-01 - 3 citationsActivity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.Tabraiz A. Mohammed, Trevor W. Dennie, Kyle D. Holen
Clinical Advances in Hematology & Oncology. 2011-06-01
Journal Articles
- A Phase I study of AT-101 with Cisplatin and Etoposide in patients with advanced solid tumors with an Expanded Cohort in Extensive-Stage Small Cell Lung Cancer.Schelman WR, Mohammed TA, Traynor AM, Kolesar JM, Marnocha RM, Eickhoff J, Keppen M, Alberti DB, Wilding G, Takebe N, Liu G, Investigational New Drugs, 1/1/2013
- Activity of Oxaliplatin plus Capecitabine (CapeOx) with Lapatinib for Metastatic Colorectal Cancer: Results from Two Patients Treated on a Clinical Study.Mohammed TA, Dennie T, Holen, KD, Clinical Advances in Hematology & Oncology, 6/1/2011
- Increasing Disparity in Colorectal Cancer Incidence and Mortality among African Americans and Whites: A State’s Experience.LoConte NK, Williamson A, Gayle A, Weiss J, Leal T, Cetnar J, Mohammed T, Tevaarwerk A, Jones N, Journal of Gastrointestinal Oncology, 1/1/2011
- Join now to see all
Abstracts/Posters
- Structural and Cytoskeletal Alterations Precede Posterior Subcapsular Cataract Formation in Royal College of Surgeons Rats.Al-Ghoul KJ, Joy A, Mohammed TA, Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 5/1/2009
Lectures
- Spirituality, Faith and Muslim Patients.Madison, WI - 3/1/2013
- Cultural competency and clinical communication: Addressing healthcare disparities in the 21st century.Madison, WI - 5/1/2012
- The role of chemotherapy in the treatment of resectable liver metastases in stage IV Colorectal Cancer.Madison, WI - 4/1/2010
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: